Ketamine has surged to the forefront of psychedelic medicine and pop culture alike ,but alongside the accolades is a growing shadow.
Hamilton Morris, Liana Gillooly, Gita Vaid
Speaker discusses underlying assumptions of psychedelic therapy and therapist's role, emphasizing presence in facilitating healing. Draws from personal experiences with MDMA, psilocybin, and ketamine research volunteers.
Norma Stevens
Psychedelic retreat centers are operating worldwide, with Oregon and Colorado preparing to regulate similar centers. These venues offer access to psychedelic experiences outside clinical settings, raising questions about their differences
Alexandra Pallas, Melissa Stangl, Ann “Annie Oak” Harrison
Dr. Ronald Duman and George Aghajanian's research on ketamine's effects on depression led to further studies on glutamate signaling and synaptic density restoration. Combining ketamine with psychotherapy or MTORC1 inhibitors
John H Krystal
Ketamine and other psychedelics show promise for psychiatric disorders, but their psychoactive effects complicate masking in trials. A triple-masked trial on 40 patients with depression found surprising results.
Boris D. Heifets
Ketamine and psilocybin show promise for health conditions but come with risks, including addiction. This talk challenges the view of drugs as neutral tools and explores their complex nature and
Elias Dakwar
KAP program offers innovative treatment for adolescents with emotional issues, focusing on family involvement. Successes and challenges of this unique approach are discussed.
Phil Wolfson
Psychedelic-assisted therapies for adolescents are discussed, including the use of ketamine for treatment-resistant depression and the need for further studies and careful consideration of risks. Traditional use of plant medicines
Corine de Boer, Rebecca Kronman, Glauber Assis
Dr. Ben Sessa will discuss similarities among MDMA, ketamine, and psilocybin in clinical settings, exploring their potential in treating trauma-based disorders and challenges in psychedelic medicalization.
Ben Sessa
Dr. Bennett explores the expanding field of ketamine treatment, covering current trends, controversies, and potential topics like enantiomers, mail order platforms, provider training, economics, and FDA approval challenges.
© 1986 – 2025 Multidisciplinary Association for Psychedelic Studies. All Rights Reserved.
3141 Stevens Creek Blvd #40563, San Jose, CA 95117.
Mailing: MAPS P.O. Box 103004 Pasadena, CA 91189-3004.